Painless ultrasound may replace needle biopsy for Kids' liver disease

NCT ID NCT01072721

First seen Nov 20, 2025 · Last updated Apr 28, 2026 · Updated 16 times

Summary

This study tested whether a noninvasive ultrasound device called FibroScan can accurately measure liver scarring (fibrosis) in children. Currently, the only reliable method is a liver biopsy, which involves inserting a needle into the liver. The study included 264 children aged 6 months to 18 years with various liver conditions. If proven effective, FibroScan could help many children avoid the pain and risks of a biopsy.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CIRRHOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Necker Hospital

    Paris, 75015, France

Conditions

Explore the condition pages connected to this study.